Dupilumab in Persistent Asthma with Elevated Eosinophil Levels
Inhibiting Interleukin-4 and Interleukin-13 in Difficult-to-Control Asthma
I have a son who’s asthmatic on the far end of severe. God willing this med will help.
Save
PING
Of course, being a MAB derived drug, it will be hugely expensive. It will therefore fall outside of the preferred drug list of ObamaCare. No matter how effective it might be.
Regeneron will have to weigh the costs to get it through the FDA vs the likelihood of being a first line agent approved for use by Obama’s minions. God help those companies driven to innovate.